707 F.3d 223 (3rd Cir. 2013), 11-3602, France v. Abbott Laboratories
Linked as:
Extract
707 F.3d 223 (3rd Cir. 2013), 11-3602, France v. Abbott Laboratories
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Procedure for submission of an application requiring investigations for approval of a new indication for, or other change from, a listed drug
- Code of Federal Regulations - Approval of an NDA and an ANDA
- US Code - 21 U.S.C. § 301 Short Title
- US Code - 21 U.S.C. § 360cc Protection For Drugs For Rare Diseases Or Conditions
- US Code - 28 U.S.C. § 1291 Final Decisions of District Courts